Evidence map›Paper›PMID 15673729›Full record

ArticleAntimicrobial agents and chemotherapy2005

Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents.

K R Fiebelkorn, S A Crawford, J H Jorgensen

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Progression of antibiotic resistance inClinical microbiology reviews · 2025
    Review
  3. Article
  4. Article
  5. Continuing genomic evolution of theMicrobial genomics · 2023
    Review
  6. Article
  7. Carriage ofInfection and drug resistance · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

K R FiebelkornDepartment of Pathology, University of Texas Health Science Center, 7703 Floyd Curl Dr., MC 7750, San Antonio, TX 78229-3750, USA. fiebelkorn@uthscsa.edu
S A Crawford
J H Jorgensen
The University of Texas Health Science Center at San Antonio · USThe University of Texas Health Science Center · US

Funding

DRS NIH HHS RS1 CCR622402
6 · The paper itself

Abstract

Sulfonamide resistance in meningococci is associated with mutations in the chromosomal gene folP, which encodes dihydropteroate synthase. Several mutations associated with resistance have been previously described, including amino acid substitutions at codons 31 and 194, a glycine-serine insertion at codons 195 and 196, and, recently, an additional mutation at nucleotide 682 (C682A). In this study, sulfisoxazole MICs were determined for 424 geographically diverse clinical isolates of Neisseria meningitidis, including all major subtypes. A subset of 134 isolates with MICs ranging from 0.5 to >64 microg/ml were assayed for the C682A mutation by real-time PCR, and 25 isolates were selected for folP gene sequencing. All isolates for which the sulfisoxazole MIC was >/=8 possessed the C682A mutation by real-time PCR or folP sequencing, and 34 of 35 isolates with a MIC of </=2 lacked this mutation. Of 16 sequenced isolates for which the sulfisoxazole MIC was >/=4, 15 possessed previously described mutations, including 10 at codon 31, 1 at codon 194, and 4 with the 2-amino-acid insertion codons 195 and 196; all 16 possessed the C682A mutation. The C682A mutation predicted elevated sulfonamides MICs for a large number of geographically diverse clinical isolates of meningococci. Detection of this mutation by real-time PCR or other methods may allow more wide-scale detection of meningococcal isolates with for which the sulfonamide MICs are elevated without resorting to multiple assays or folP gene sequencing, providing a simple, high-throughput screening method for use in public health and epidemiologic settings.

Indexed as

Anti-Bacterial AgentsDihydropteroate SynthaseDNA, BacterialDrug Resistance, BacterialHumansMeningococcal InfectionsMicrobial Sensitivity TestsMolecular Sequence DataMutationNeisseria meningitidisQuality ControlReverse Transcriptase Polymerase Chain ReactionSulfonamidesAnti-Bacterial AgentsDihydropteroate SynthaseDNA, BacterialSulfonamides

Identifiers

PMID15673729
PMCPMC547345
OpenAlexW2168037695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.